מדינה: הממלכה המאוחדת
שפה: אנגלית
מקור: MHRA (Medicines & Healthcare Products Regulatory Agency)
Rifampicin
Sanofi
J04AB02
Rifampicin
300mg
Oral capsule
Oral
No Controlled Drug Status
Valid as a prescribable product
BNF: 05010900; GTIN: 5015265300043
TURN OVER _I_ IMPORTANT THINGS YOU NEED TO KNOW ABOUT RIFADIN 300MG CAPSULES • It is very important that you take Rifadin 300mg Capsules exactly as your doctor has told you. There is a chance of you having a severe and dangerous allergic reaction if you do not take Rifadin 300mg Capsules each day as you are told • You must keep taking Rifadin 300mg Capsules until your doctor tells you to stop. • If you are taking any other medicines, including medicines you have bought from the pharmacy or shop, you must make sure your doctor knows • Rifadin 300mg Capsules make all your body fluids an orange or red colour. Do not worry - this is normal and not harmful • Take Rifadin 300mg Capsules on an empty stomach. This means at least 30 minutes before food or 2 hours after food • If you get a temperature, are sick, begin to feel more unwell, lose your appetite or have yellowing of the skin, gums or eyes, you must talk to your doctor straight away READ THE REST OF THIS LEAFLET CAREFULLY BEFORE YOU START TAKING THIS MEDICINE. • Keep this leaflet. You may need to read it again. • If you have any further questions, ask your doctor or your pharmacist. • This medicine has been prescribed for you. Do not pass it to others. It may harm them, even if their symptoms are the same as yours. • If any of the side effects gets serious, or if you notice any side effects not listed in this leaflet, please tell your doctor or pharmacist. WHAT IS IN THIS LEAFLET: 1. What Rifadin 300mg Capsules are and what they are used for 2. What you need to know before you take Rifadin 300mg Capsules 3. How to take Rifadin 300mg Capsules 4. Possible side effects 5. How to store Rifadin 300mg Capsules 6. Contents of the pack and other information 1. WHAT RIFADIN 300MG CAPSULES ARE AND WHAT THEY ARE USED FOR Rifadin 300mg Capsules contain a medicine called rifampicin. It belongs to a group of medicines called anti-bacterials. It works by killing the bacteria that cause infections. Rifadin 300mg Capsules are used to treat the following bacte קרא את המסמך השלם
SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE MEDICINAL PRODUCT Rifadin 300mg Capsules 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Rifampicin Ph Eur 300 mg For a full list of excipients, see section 6.1. 3 PHARMACEUTICAL FORM Capsule, hard. The gelatin capsule is opaque, composed of a scarlet body and cap, marked R-300. 4.1 THERAPEUTIC INDICATIONS Indications for use Tuberculosis: In combination with other active anti-tuberculosis drugs in the treatment of all forms of tuberculosis, including fresh, advanced, chronic and drug-resistant cases. Rifadin is also effective against most atypical strains of Mycobacteria. Leprosy: In combination with at least one other active anti-leprosy drug in the management of multibacillary and paucibacillary leprosy to effect conversion of the infectious state to a non-infectious state. Other Infections: In the treatment of Brucellosis, Legionnaires Disease, and serious staphylococcal infections. To prevent emergence of resistant strains of the infecting organisms, Rifadin should be used in combination with another antibiotic appropriate for the infection. Prophylaxis of meningococcal meningitis: For the treatment of asymptomatic carriers of N. meningitidis to eliminate meningococci from the nasopharynx. Haemophilus influenzae: For the treatment of asymptomatic carriers of H.influenzae and as chemoprophylaxis of exposed children, 4 years of age or younger. 4.2 POSOLOGY AND METHOD OF ADMINISTRATION Recommended Dosage For oral administration The daily dose of Rifadin, calculated from the patient’s body weight, should preferably be taken at least 30 minutes before a meal or 2 hours after a meal to ensure rapid and complete absorption. Tuberculosis: Rifadin should be given with other effective anti-tuberculosis drugs to prevent the possible emergence of rifampicin-resistant strains of Mycobacteria. _Adults_: The recommended single daily dose in tuberculosis is 8-12 mg/kg. _Usual Daily dose_: Patients weighing less than 50 kg - 450 mg. Patients weighing 50 kg or more – 600 mg. _Ch קרא את המסמך השלם